Related references
Note: Only part of the references are listed.Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
Silvio Danese et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation
Masahiro Kishi et al.
JOURNAL OF GASTROENTEROLOGY (2022)
Management of perianal fistulas in Crohn's disease: a 2021 update of the French National Society of Coloproctology consensus
D. Bouchard et al.
TECHNIQUES IN COLOPROCTOLOGY (2022)
Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study
Foong Way D. Tai et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn's Disease
Feihong Deng et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Assessment of a new score for capsule endoscopy in pediatric Crohn's disease (CE- CD)
Salvatore Oliva et al.
ENDOSCOPY INTERNATIONAL OPEN (2021)
Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission
Kaoru Takabayashi et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Lewis score on capsule endoscopy can predict the prognosis in patients with small bowel lesions of Crohn's disease
Takahiro Nishikawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Bowel Ultrasound: A Non-invasive, Easy to Use Method to Predict the Need to Intensify Therapy in Inflammatory Bowel Disease Patients
Anda Les et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner et al.
GASTROENTEROLOGY (2021)
Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease A retrospective cohort study
Yuga Komaki et al.
MEDICINE (2021)
Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study
Joo Hye Song et al.
GUT AND LIVER (2021)
Predictors of reoperation for perianal fistula in Crohn's disease
Kwangwoo Nam et al.
JOURNAL OF DIGESTIVE DISEASES (2021)
Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission
Takahiro Miyazu et al.
MEDICINE (2021)
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study
Maria Jose Casanova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Pedictors of Perianal Fistula Relapse in Crohn's Disease
Audrey Malian et al.
INFLAMMATORY BOWEL DISEASES (2020)
Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis
Edward L. Barne et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Anti-TNF dose escalation and drug sustainability in Crohn's disease: Data from the nationwide administrative database in Hungary
Fruzsina Kosa et al.
DIGESTIVE AND LIVER DISEASE (2020)
Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease
Jeffrey D. McCurdy et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype
Yoichi Kakuta et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures
Julien D. Schulberg et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing
Britt Christensen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2020)
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease
Shigeki Bamba et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Objective evaluation for treat to target in Crohn's disease
Kento Takenaka et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Bing Zhang et al.
JOURNAL OF CROHNS & COLITIS (2020)
The shining DIAMOND for evidence-based treatment strategies for Crohn's disease
Hiroshi Nakase et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further?
Arianna Dal Buono et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
De-escalation of medical therapy in inflammatory bowel disease
Catarina Frias Gomes et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Systematic review with meta-analysis: efficacy of balloon-assisted enteroscopy for dilation of small bowel Crohn's disease strictures
Dominik Bettenworth et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response
Mark A. Samaan et al.
FRONTLINE GASTROENTEROLOGY (2020)
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2020)
Utility of proactive infliximab levels in paediatric Crohn's disease
Christopher J. Burgess et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children
Wael El-Matary et al.
INFLAMMATORY BOWEL DISEASES (2019)
Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus
A. Hillary Steinhart et al.
INFLAMMATORY BOWEL DISEASES (2019)
A value proposition for trough level-based anti-TNFα drug dosing
V. Scharnhorst et al.
CLINICA CHIMICA ACTA (2019)
Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease
Konstantinos Papamichael et al.
JOURNAL OF CROHNS & COLITIS (2019)
Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease
Shintaro Sagami et al.
PLOS ONE (2019)
Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients
Alice Jane Foster et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review
Dominik Bettenworth et al.
GUT (2019)
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)
Tadakazu Hisamatsu et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
Anne S. Strik et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
How to manage anal ulcerations and anorectal stenosis in Crohn's disease: algorithm-based decision making: French National Working Group Consensus 2018
D. Bouchard et al.
TECHNIQUES IN COLOPROCTOLOGY (2019)
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring
Amit Assa et al.
GASTROENTEROLOGY (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study
Mathurin Fumery et al.
DIGESTIVE AND LIVER DISEASE (2019)
Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease
Maria Jesus Martinez et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort
Mirabella Zhao et al.
INFLAMMATORY BOWEL DISEASES (2019)
Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up
G. R. Jones et al.
JOURNAL OF CROHNS & COLITIS (2019)
Impact of therapeutic drug level monitoring on outcomes of patients with Crohn's disease treated with Infliximab: real world data from a retrospective single centre cohort study
Nikolaos Kamperidis et al.
FRONTLINE GASTROENTEROLOGY (2019)
Targeting mucosal healing in Crohn's disease: what the clinician needs to know
Entcho Klenske et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Statement of the expert group on the current practice and prospects for the treatment of complex perirectal fistulas in the course of Crohn's disease
Tomasz Banasiewicz et al.
POLISH JOURNAL OF SURGERY (2019)
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
Taketo Suzuki et al.
CASE REPORTS IN GASTROENTEROLOGY (2019)
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
Yoram Bouhnik et al.
GUT (2018)
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial
Thomas Van Stappen et al.
GUT (2018)
Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn's Disease: Systematic Review and Meta-Analysis
Diana E. Yung et al.
INFLAMMATORY BOWEL DISEASES (2018)
Efficacy of Endoscopic Balloon Dilation for Small Bowel Strictures in Patients With Crohn's Disease: A Nationwide, Multi-centre, Open-label, Prospective Cohort Study
Fumihito Hirai et al.
JOURNAL OF CROHNS & COLITIS (2018)
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease
Glen Doherty et al.
JOURNAL OF CROHNS & COLITIS (2018)
Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
Yoichi Kakuta et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor- in patients with Crohn's disease
Sandra Bohn Thomsen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens et al.
GASTROENTEROLOGY (2018)
Impact of capsule endoscopy on prevention of postoperative recurrence of Crohn's disease
Ze-min Han et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Effects of Perianal Involvement on Clinical Outcomes in Crohn's Disease over 10 Years
Jin Young Yoon et al.
GUT AND LIVER (2018)
Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNFα Treatment Discontinuation
Clemence Legue et al.
INFLAMMATORY BOWEL DISEASES (2018)
Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab
Sophie Restellini et al.
INFLAMMATORY BOWEL DISEASES (2018)
Anal Fistulas in Severe Perineal Crohn's Disease: Mri Assessment in the Determination of Long-Term Healing Rates
Charlene Brochard et al.
INFLAMMATORY BOWEL DISEASES (2018)
Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis
Grant E. Barber et al.
INFLAMMATORY BOWEL DISEASES (2018)
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2
Frank M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2018)
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease
Daniel R. Hoekman et al.
JOURNAL OF CROHNS & COLITIS (2018)
P575 Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
L Guidi et al.
Journal of Crohns & Colitis (2018)
Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials
Remo Panaccione et al.
JOURNAL OF CROHNS & COLITIS (2018)
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
Yoichi Kakuta et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease
David H. Bruining et al.
RADIOLOGY (2018)
Endoscopic management of Crohn's strictures
Talat Bessissow et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing
Bram Verstockt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease
Jordan E. Axelrad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting
Maria Gloria Mumolo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
A risk score system to timely manage treatment in Crohn's disease: a cohort study
Nadia Pallotta et al.
BMC GASTROENTEROLOGY (2018)
Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease
Cristina Verdejo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Burden and outcomes for complex perianal fistulas in Crohn's disease: Systematic review
Julian Panes et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Validity of Capsule Endoscopy in Monitoring Therapeutic Interventions in Patients with Crohn's Disease
Masanao Nakamura et al.
JOURNAL OF CLINICAL MEDICINE (2018)
How are we managing fistulating perianal Crohn's disease? Results of a national survey of consultant gastroenterologists
Matthew James Lee et al.
FRONTLINE GASTROENTEROLOGY (2018)
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis
Yuen Sau Tham et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Endoscopic Surveillance in Inflammatory Bowel Disease
Martin Goetz
VISCERAL MEDICINE (2018)
Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease
Kento Takenaka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors
Aisaku Osamura et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response
E. Dreesen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
Shiro Nakamura et al.
INTESTINAL RESEARCH (2018)
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
M. J. Casanova et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations
Paolo Gionchetti et al.
JOURNAL OF CROHNS & COLITIS (2017)
Magnetic resonance evaluation for small bowel strictures in Crohn's disease: comparison with balloon enteroscopy
Kento Takenaka et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents
Pauliina Molander et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2017)
American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Joseph D. Feuerstein et al.
GASTROENTEROLOGY (2017)
Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
So Yoon Choi et al.
GUT AND LIVER (2017)
Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience
Pablo Olivera et al.
INFLAMMATORY BOWEL DISEASES (2017)
Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis
Laura E. Targownik et al.
INFLAMMATORY BOWEL DISEASES (2017)
Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease
Geoffrey C. Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2017)
A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease
Dominik Bettenworth et al.
INFLAMMATORY BOWEL DISEASES (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis
Xiao Qiu et al.
MEDICINE (2017)
Anoperineal lesions in Crohn's disease: French recommendations for clinical practice
D. Bouchard et al.
TECHNIQUES IN COLOPROCTOLOGY (2017)
The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease
J. Rayen et al.
TECHNIQUES IN COLOPROCTOLOGY (2017)
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease
Yun Qiu et al.
STEM CELL RESEARCH & THERAPY (2017)
Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers
Takayuki Yamamoto et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new biological era
Amy L. Lightner et al.
GASTROENTEROLOGY REPORT (2017)
Endoscopic Balloon Dilation for Crohn's Disease-Associated Strictures
Thomas Klag et al.
CLINICAL ENDOSCOPY (2017)
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases
N. Mitrev et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease
James O. Lindsay et al.
DIGESTIVE AND LIVER DISEASE (2017)
Anal ulcerations in Crohn's disease: Natural history in the era of biological therapy
Timothee Wallenhorst et al.
DIGESTIVE AND LIVER DISEASE (2017)
Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
Lorant Gonczi et al.
BMC GASTROENTEROLOGY (2017)
Discontinuation of Scheduled Infliximab in Crohn's Patients With Clinical Remission: A Retrospective Single-Center Study
Huiqin Hu et al.
GASTROENTEROLOGY RESEARCH (2017)
Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease
Y. Derwa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
Cheng-Chun Ji et al.
INTESTINAL RESEARCH (2017)
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial
X. Roblin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Proposal for an anti-TNF-exit strategy based on trough serum level
Ulf Helwig et al.
BIOLOGICALS (2017)
French national consensus clinical guidelines for the management of Crohn's disease
Laurent Peyrin-Biroulet et al.
DIGESTIVE AND LIVER DISEASE (2017)
Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease
A. J. Yarur et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable Cost
Ann Gils
DIGESTIVE DISEASES (2017)
Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab
Nicolas Duveau et al.
DIGESTIVE AND LIVER DISEASE (2017)
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
L. Vuitton et al.
GUT (2016)
Contrast-enhanced Ultrasound for Detection of Crohn's Disease Activity: Systematic Review and Meta-analysis
Zbigniew Serafin et al.
JOURNAL OF CROHNS & COLITIS (2016)
Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice
Javier Ampuero et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
Tariq Ahmad et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases
Rahul Kalla et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results
Gil Y. Melmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease
Marla C. Dubinsky et al.
INFLAMMATORY BOWEL DISEASES (2016)
Correlation Between Calprotectin and Modified Rutgeerts Score
Susana Lopes et al.
INFLAMMATORY BOWEL DISEASES (2016)
Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: Which One Is the Best for What?
Astrid-Jane Greenup et al.
INFLAMMATORY BOWEL DISEASES (2016)
World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015
Charles N. Bernstein et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment
Ben Kang et al.
JOURNAL OF CROHNS & COLITIS (2016)
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease
Florian Rieder et al.
JOURNAL OF CROHNS & COLITIS (2016)
Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease
Phillip Minar et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
Endoscopic balloon dilation in the management of strictures in Crohn's disease: a systematic review and meta-analysis of non-randomized trials
Udayakumar Navaneethan et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2016)
How to predict clinical relapse in inflammatory bowel disease patients
Elisa Liverani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Assessment of stricturing Crohn's disease: Current clinical practice and future avenues
Dominik Bettenworth et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Usefulness of Endoscopic Indices in Determination of Disease Activity in Patients with Crohn's Disease
Marcin Kucharski et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study
Barbara M. Iwanczak et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study
Takayuki Yamamoto et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study
Takayuki Yamamoto et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
American Gastroenterological Institute Guideline on the Management of Crohn’s Disease After Surgical Resection: Clinical Decision Support Tool
GASTROENTEROLOGY (2016)
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Long-Term Outcome of Patients With Crohn's Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
Konstantinos Papamichael et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Therapeutic Strategy for Crohn's Disease with a Loss of Response to Infliximab: A Single-Center Retrospective Study
Yutaka Nagata et al.
DIGESTION (2015)
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab
Casper Steenholdt et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation
Nikos Viazis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Grading of Crohn's disease activity using CT, MRI, US and scintigraphy: a meta-analysis
C. A. J. Puylaert et al.
EUROPEAN RADIOLOGY (2015)
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Niels Vande Casteele et al.
GASTROENTEROLOGY (2015)
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
Joana Torres et al.
GASTROENTEROLOGY (2015)
Extraintestinal Manifestations of Inflammatory Bowel Disease
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response
S. Ghaly et al.
INTERNAL MEDICINE JOURNAL (2015)
Changes in Serum Trough Levels of Infliximab During Treatment Intensification but not in Anti-infliximab Antibody Detection are Associated with Clinical Outcomes after Therapeutic Failure in Crohn's Disease
Casper Steenholdt et al.
JOURNAL OF CROHNS & COLITIS (2015)
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
X. Roblin et al.
JOURNAL OF CROHNS & COLITIS (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz et al.
LANCET (2015)
A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD)
Shunichi Odahara et al.
PLOS ONE (2015)
Disease monitoring in inflammatory bowel disease
Shannon Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn's Disease
Heimo H. Wenzl et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
High-Dose Infliximab Therapy in Crohn's Disease: Clinical Experience, Safety, and Efficacy
Steven A. Hendler et al.
JOURNAL OF CROHNS & COLITIS (2015)
Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease - clinical observations from a tertiary Eastern European center
Renata Bor et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Diagnosis and monitoring of postoperative recurrence in Crohn's disease
Takayuki Yamamoto
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Indian Society of Gastroenterology consensus statements on Crohn's disease in India
Balakrishnan Ramakrishna et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2015)
Examining the whole bowel, double balloon enteroscopy: Indications, diagnostic yield and complications
Fatih Saygili et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2015)
Intestinal Stricture in Crohn's Disease
Chen-Wang Chang et al.
INTESTINAL RESEARCH (2015)
Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy
Carlos Castaño-Milla et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
N. A. Kennedy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
Xavier Roblin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Capsule Endoscopy Is Superior to Small-bowel Follow-through and Equivalent to Ileocolonoscopy in Suspected Crohn's Disease
Jonathan A. Leighton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Addressing current treatment challenges in Crohn's disease in real life: A physician's survey
Stephan R. Vavricka et al.
DIGESTIVE AND LIVER DISEASE (2014)
Long-term outcome of endoscopic balloon dilation for small bowel strictures in patients with Crohn's disease
Fumihito Hirai et al.
DIGESTIVE ENDOSCOPY (2014)
Su1394 Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease
Konstantinos Papamichail et al.
GASTROENTEROLOGY (2014)
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial
Casper Steenholdt et al.
GUT (2014)
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
Krisztina B. Gecse et al.
GUT (2014)
A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy
Barry Hall et al.
JOURNAL OF CROHNS & COLITIS (2014)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
Evaluation of diagnostic criteria for Crohn's disease in Japan
Takashi Hisabe et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Use of capsule endoscopy in patients with Crohn's disease in Japan: A multicenter survey
Motohiro Esaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?
R. J. Dart et al.
FRONTLINE GASTROENTEROLOGY (2014)
Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy
James Turvill
FRONTLINE GASTROENTEROLOGY (2014)
Measuring disease activity in Crohn's disease: what is currently available to the clinician
Renata D'Inca et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
T. Molnar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
Jonathan P. Terdiman et al.
GASTROENTEROLOGY (2013)
Crohn's disease complicated by strictures: a systematic review
Florian Rieder et al.
GUT (2013)
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
J. Panes et al.
JOURNAL OF CROHNS & COLITIS (2013)
Sexual function and quality of life after surgical treatment for anal fistulas in Crohn's disease
S. Riss et al.
TECHNIQUES IN COLOPROCTOLOGY (2013)
Review article: the natural history of postoperative Crohn's disease recurrence
A. Buisson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Epidemiology of the Transition from Early to Late Crohn's Disease
Edouard Louis
DIGESTIVE DISEASES (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Long-term MRI-guided combined anti-TNF-a and thiopurine therapy for crohn's perianal fistulas
Phil Tozer et al.
INFLAMMATORY BOWEL DISEASES (2012)
Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease
Toshiaki Watanabe et al.
INFLAMMATORY BOWEL DISEASES (2012)
Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: Prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation
Frank Lenze et al.
INFLAMMATORY BOWEL DISEASES (2012)
P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study
N. de Suray et al.
Journal of Crohns & Colitis (2012)
Inflammatory bowel disease in Asia: A systematic review
Lani Prideaux et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Small bowel imaging in Crohn's disease
Helen Bungay
FRONTLINE GASTROENTEROLOGY (2012)
Quality of Life in Perianal Crohn's Disease: What Do Patients Consider Important?
Srihari Mahadev et al.
DISEASES OF THE COLON & RECTUM (2011)
Crohn's Disease Activity Index Does Not Correlate with Endoscopic Recurrence One Year After Ileocolonic Resection
Miguel Regueiro et al.
INFLAMMATORY BOWEL DISEASES (2011)
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Current Smoking, Not Duration of Remission, Delays Crohn's Disease Relapse Following Azathioprine Withdrawal
Harry Sokol et al.
INFLAMMATORY BOWEL DISEASES (2010)
Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2010)
Review: Optimal use of biologics in the management of Crohn’s disease
Remo Panaccione et al.
Therapeutic Advances in Gastroenterology (2010)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Crohn Disease of the Small Bowel: Comparison of CT Enterography, MR Enterography, and Small-Bowel Follow-Through as Diagnostic Techniques
Seung Soo Lee et al.
RADIOLOGY (2009)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial
Craig A. Solem et al.
GASTROINTESTINAL ENDOSCOPY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Imaging of the small bowel in Crohn's disease: A review of old and new techniques
Simone Saibeni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis
Nicholas C. Gourtsoyiannis et al.
EUROPEAN RADIOLOGY (2006)
Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis
G. Masselli et al.
ABDOMINAL IMAGING (2006)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease:: increased relapse rate the following year
M Vilien et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Review article: Crohn's disease: monitoring disease activity
R Sostegni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
AGA technical review on perianal Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
Share Paper
